210963-93-2

Basic information

• Product Name: 5-BROMO-2-(PYRROLIDIN-1-YL)PYRIDINE
• Synonyms: 5-BROMO-2-(PYRROLIDIN-1-YL)PYRIDINE;N-(5-Bromopyridin-2-yl)pyrrolidine;2-pyrrolidinyl-5-bromopyridine;1-(5-Bromopyridin-2-yl)pyrrolidine, 1-(5-Bromopyridin-2-yl)-2,3,4,5-tetrahydropyrrole
• CAS NO: 210963-93-2
• Molecular Formula: C₉H₁₁BrN₂
• Molecular Weight: 227.1
• Product Categories: Organohalides;Pyridine;alkyl bromide
• Mol File: 210963-93-2.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 318.335 °C at 760 mmHg
• Flash Point: 146.324 °C
• Appearance: /
• Density: 1.481 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.597
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 5-BROMO-2-(PYRROLIDIN-1-YL)PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-(PYRROLIDIN-1-YL)PYRIDINE(210963-93-2)
• EPA Substance Registry System: 5-BROMO-2-(PYRROLIDIN-1-YL)PYRIDINE(210963-93-2)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-36/37/38
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 210963-93-2(Hazardous Substances Data)

Usage

Chemical Properties

Yellow solid

InChI:InChI=1/C9H11BrN2/c10-8-3-4-9(11-7-8)12-5-1-2-6-12/h3-4,7H,1-2,5-6H2

Upstream product

• 123-75-1 pyrrolidine 
• 53939-30-3 5-bromo-2-chloropyridine 
• 110-52-1 1,4-dibromo-butane 
• 1072-97-5 5-bromo-2-pyridylamine 
• 624-28-2 2,5-dibromopyridine 

Downstream Products

• 494771-62-9 5-iodo-2-(pyrrolidin-1-yl)pyridine 
• 90839-82-0 2-(pyrrolidin-1-yl)-5-cyanopyridine 
• 1150114-75-2 (6-(pyrrolidin-1-yl)pyridin-3-yl)boronic acid 
• 210963-94-3 6-(N-pyrrolidinyl)nicotinic acid methyl ester 

Relevant articles and documents

Co(II)-Catalyzed Regioselective Pyridine C-H Coupling with Diazoacetates

A Co(II)-catalyzed pyridyl C-H bond carbenoid insertion with α-diazoacetates has been realized. This transformation features a highly regioselective C-C bond formation at the C3-position of pyridines, providing an efficient access to diverse α-aryl-α-pyri

NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES

The invention relates to novel chemical compounds of general formula I, in which L A , L B , L C , ring A, ring B, R A , R B , R C ,R D ,R E and R F have are defined in the description, and which are protein kinases inhibitors. The invention also relates

ALLOSTERIC MODULATORS OF THE CANNIBINOID 1 RECEPTOR

The present technology relates to compounds and compositions of Formulas I, II, VII, and VIII, and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of addiction, metabolic syndrome, obesity, and/or a CB1 receptor-medited disorder.